Double Medical Technology (SZSE:002901) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Simply Wall St19:18 ET

Dabo Healthcare: Report for the third quarter of 2024

SZSIOct 30 12:00 ET · Announcements

Double Medical Technology Inc. (002901.SZ): net income of 0.24 billion yuan in the first three quarters, a year-on-year increase of 145.48%.

Double Medical Technology Inc. (002901.SZ) announced its third quarter report for 2024 on October 30th. The company achieved revenue of 1.529 billion yuan in the first three quarters, a year-on-year increase of 35.88%; net income attributable to shareholders of the listed company was 0.24 billion yuan, a year-on-year increase of 145.48%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.211 billion yuan, a year-on-year increase of 297.20%; basic earnings per share were 0.5794 yuan.

Gelonghui FinanceOct 30 09:05 ET

double medical technology inc. (002901.SZ): has repurchased 1.05% of the shares.

On October 16, Gelunhui reported that as of October 16, 2024, Double Medical Technology Inc. (002901.SZ) announced that the company has repurchased a total of 4,361,800 shares through a repurchase special security account in a centralized competitive bidding trading manner, accounting for 1.0535% of the total share capital. The highest fill price was 33.00 yuan/share, the lowest fill price was 24.37 yuan/share, and the total fill amount was RMB 0.132 billion (excluding transaction costs).

Gelonghui FinanceOct 16 05:16 ET

Why Investors Shouldn't Be Surprised By Double Medical Technology Inc.'s (SZSE:002901) 28% Share Price Surge

Simply Wall StSep 27 21:00 ET

Double Medical Technology Inc. (002901.SZ): plans to launch 8 million shares of stock options incentive plan.

Gelonghui, September 10th | Double Medical Technology Inc. (002901.SZ) announced its stock option incentive plan for 2024, with the plan proposing to grant 8 million stock options to incentive targets, accounting for approximately 1.93% of the total share capital of the company on the date of the announcement of the plan, which is 414.019506 million shares. Among them, the initial grant of stock options is 7.1316 million, accounting for approximately 1.72% of the total share capital of the company on the date of the announcement of the plan, representing 89.15% of the total number of stock options to be granted under the plan; and reserving 0.8684 million shares, accounting for

Gelonghui FinanceSep 10 08:27 ET